Literature DB >> 7692452

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide.

C J Lowenstein1, E W Alley, P Raval, A M Snowman, S H Snyder, S W Russell, W J Murphy.   

Abstract

The promoter region of the mouse gene for macrophage-inducible nitric oxide synthase (mac-NOS; EC 1.14.13.39) has been characterized. A putative TATA box is 30 base pairs upstream of the transcription start site. Computer analysis reveals numerous potential binding sites for transcription factors, many of them associated with stimuli that induce mac-NOS expression. To localize functionally important portions of the regulatory region, we constructed deletion mutants of the mac-NOS 5' flanking region and placed them upstream of a luciferase reporter gene. The macrophage cell line RAW 264.7, when transfected with a minimal promoter construct, expresses little luciferase activity when stimulated by lipopolysaccharide (LPS), interferon gamma (IFN-gamma), or both. Maximal expression depends on two discrete regulatory regions upstream of the putative TATA box. Region I (position -48 to -209) increases luciferase activity approximately 75-fold over the minimal promoter construct. Region I contains LPS-related responsive elements, including a binding site for nuclear factor interleukin 6 (NF-IL6) and the kappa B binding site for NF-kappa B, suggesting that this region regulates LPS-induced expression of the mac-NOS gene. Region II (position -913 to -1029) alone does not increase luciferase expression, but together with region I it causes an additional 10-fold increase in expression. Together the two regions increase expression 750-fold over activity obtained from a minimal promoter construct. Region II contains motifs for binding IFN-related transcription factors and thus probably is responsible for IFN-mediated regulation of LPS-induced mac-NOS. Delineation of these two cooperative regions explains at the level of transcription how IFN-gamma and LPS act in concert to induce maximally the mac-NOS gene and, furthermore, how IFN-gamma augments the inflammatory response to LPS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692452      PMCID: PMC47644          DOI: 10.1073/pnas.90.20.9730

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

Authors:  P A Baeuerle
Journal:  Biochim Biophys Acta       Date:  1991-04-16

2.  Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.

Authors:  R Busse; A Mülsch
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

3.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

5.  A novel tumor necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes.

Authors:  M F Shannon; L M Pell; M J Lenardo; E S Kuczek; F S Occhiodoro; S M Dunn; M A Vadas
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

Authors:  A Ding; C F Nathan; J Graycar; R Derynck; D J Stuehr; S Srimal
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

7.  Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine.

Authors:  F Y Liew; Y Li; S Millott
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

8.  Interleukin-1 beta induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta.

Authors:  V B Schini; D C Junquero; T Scott-Burden; P M Vanhoutte
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

9.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

10.  Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene.

Authors:  D C Leitman; R C Ribeiro; E R Mackow; J D Baxter; B L West
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

View more
  232 in total

1.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

2.  Oct-1 cooperates with the TATA binding initiation complex to control rapid transcription of human iNOS.

Authors:  Sylvie Reveneau; Thodoris G Petrakis; Christopher E Goldring; Aurélie Chantôme; Jean-François Jeannin; Alena Pance
Journal:  Cell Mol Life Sci       Date:  2012-02-19       Impact factor: 9.261

3.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

4.  Mycoplasma hyopneumoniae induces pro-inflammatory cytokine and nitric oxide production through NFκB and MAPK pathways in RAW264.7 cells.

Authors:  Mi-Hyun Hwang; Dereje Damte; Joong-Su Lee; Elias Gebru; Zhi-Qiang Chang; Henrique Cheng; Byeong-Yeal Jung; Man-Hee Rhee; Seung-Chun Park
Journal:  Vet Res Commun       Date:  2010-11-23       Impact factor: 2.459

5.  Differential expression of inducible nitric oxide synthase gene by alveolar and peritoneal macrophages in lipopolysaccharide-hyporesponsive C3H/HeJ mice.

Authors:  M J Wang; K C Jeng; P C Shih
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

6.  Hepatocyte nitric oxide production is induced by Kupffer cells.

Authors:  Y Shiratori; K Ohmura; Y Hikiba; M Matsumura; T Nagura; K Okano; K Kamii; M Omata
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

7.  Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.

Authors:  Resat Cinar; Malliga R Iyer; Ziyi Liu; Zongxian Cao; Tony Jourdan; Katalin Erdelyi; Grzegorz Godlewski; Gergő Szanda; Jie Liu; Joshua K Park; Bani Mukhopadhyay; Avi Z Rosenberg; Jeih-San Liow; Robin G Lorenz; Pal Pacher; Robert B Innis; George Kunos
Journal:  JCI Insight       Date:  2016-07-21

8.  Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Authors:  Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells.

Authors:  Y Choi; M K Lee; S Y Lim; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

10.  Inhibition of the induction of the inducible nitric oxide synthase in murine brain microglial cells by sodium salicylate.

Authors:  H Kim; E Lee; T Shin; C Chung; N An
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.